Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Hellwig

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
European Neurology|October 4, 2014
Pregnancy in multiple sclerosisKerstin Hellwig
The Lancet. Neurology|April 28, 2022
Natalizumab for multiple sclerosis: the dilemma of NOVAKerstin Hellwig
Neurodegenerative Disease Management|November 28, 2015
Multiple sclerosis and family planningKerstin Hellwig
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2018
We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - NoKerstin Hellwig
Current Opinion in Neurology|March 12, 2021
Use of disease-modifying drugs during pregnancy and breastfeedingRuth Dobson, Kerstin Hellwig
Neurology|April 13, 2011
Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?Kerstin Hellwig, Ralf Gold
Journal of Neurology|June 8, 2011
Progressive multifocal leukoencephalopathy and natalizumabKerstin Hellwig, Ralf Gold
Clinical Immunology (Orlando, Fla.)|March 20, 2013
Artificial reproductive techniques in multiple sclerosisKerstin Hellwig, Jorge Correale
Continuum (Minneapolis, Minn.)|April 2, 2026
Family Planning in Neuroinflammatory DiseaseRuth Dobson, Kerstin Hellwig
Journal of Neurology|September 30, 2010
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosisKerstin Hellwig, Ralf Gold
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
European Neurology|October 4, 2014
Pregnancy in multiple sclerosisKerstin Hellwig
The Lancet. Neurology|April 28, 2022
Natalizumab for multiple sclerosis: the dilemma of NOVAKerstin Hellwig
Neurodegenerative Disease Management|November 28, 2015
Multiple sclerosis and family planningKerstin Hellwig
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2018
We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - NoKerstin Hellwig
Current Opinion in Neurology|March 12, 2021
Use of disease-modifying drugs during pregnancy and breastfeedingRuth Dobson, Kerstin Hellwig
Neurology|April 13, 2011
Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?Kerstin Hellwig, Ralf Gold
Journal of Neurology|June 8, 2011
Progressive multifocal leukoencephalopathy and natalizumabKerstin Hellwig, Ralf Gold
Clinical Immunology (Orlando, Fla.)|March 20, 2013
Artificial reproductive techniques in multiple sclerosisKerstin Hellwig, Jorge Correale
Continuum (Minneapolis, Minn.)|April 2, 2026
Family Planning in Neuroinflammatory DiseaseRuth Dobson, Kerstin Hellwig
Journal of Neurology|September 30, 2010
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosisKerstin Hellwig, Ralf Gold
Pageof 20